Tumor antigen-specific T cell clones represent a useful tool in tumor immunology; however, their long-term culture is limited. To generate an immortalized cytotoxic T cell clone against the human tumor antigen mucin, we exposed a previously generated T cell culture to Herpesvirus saimiri. We obtained an immortalized human CD4+ T cell clone, termed SITAM. Clonality of these cells was shown by analysis of the {alpha}/{beta}-T cell receptor (TCR) repertoire. Cytolytic activity was demonstrated against several mucin-expressing tumor cell lines and could not be detected against non-mucin-expressing cells. SITAM cells maintained their features stably for 2 years. Furthermore, growth of the tumor cell line Capan-2 in NOD/SCID mice was inhibited wh...
Engineering the immune system against cancer ideally provides surgical precision against the antigen...
Successful ex-vivo priming and long-term maintenance of anti-tumor cytotoxic T-cell (CTL) lines are ...
Transplantation experiments have demonstrated that most mouse tumors express antigens that can const...
Immunotherapy for cancer aims to generate cytotoxic cells that are capable of eradicating tumour cel...
International audienceA CD8+ clone, identified by its T-cell receptor gamma- and beta-gene configura...
International audienceIn vitro culture of metastatic melanoma fragments with 150 units of recombinan...
Adoptive transfer of T cells genetically modified with tumour-specific T-cell receptors (TCR) is a p...
Adoptive cell immunotherapy for human diseases, including the use of T cells modified to express an ...
The clinical success of adoptive immunotherapy of cancer relies on the selection of target antigens ...
Cell-mediated immune response to breast tumor has only been marginally investigated. To gain insight...
MUC1 glycoprotein is overexpressed on the surface of a variety of epithelial tumors and has been und...
Human T cells stimulated in secondary allogeneic mixed lymphocyte culture (MLC) were cloned under li...
Inhibitory receptors on natural killer cells and on a minority of T lymphocytes are major histocompa...
The development of a T cell receptor transgenic mouse would be useful in research concerning the imm...
Adoptive cell immunotherapy for human diseases, including the use of T cells modified to express an ...
Engineering the immune system against cancer ideally provides surgical precision against the antigen...
Successful ex-vivo priming and long-term maintenance of anti-tumor cytotoxic T-cell (CTL) lines are ...
Transplantation experiments have demonstrated that most mouse tumors express antigens that can const...
Immunotherapy for cancer aims to generate cytotoxic cells that are capable of eradicating tumour cel...
International audienceA CD8+ clone, identified by its T-cell receptor gamma- and beta-gene configura...
International audienceIn vitro culture of metastatic melanoma fragments with 150 units of recombinan...
Adoptive transfer of T cells genetically modified with tumour-specific T-cell receptors (TCR) is a p...
Adoptive cell immunotherapy for human diseases, including the use of T cells modified to express an ...
The clinical success of adoptive immunotherapy of cancer relies on the selection of target antigens ...
Cell-mediated immune response to breast tumor has only been marginally investigated. To gain insight...
MUC1 glycoprotein is overexpressed on the surface of a variety of epithelial tumors and has been und...
Human T cells stimulated in secondary allogeneic mixed lymphocyte culture (MLC) were cloned under li...
Inhibitory receptors on natural killer cells and on a minority of T lymphocytes are major histocompa...
The development of a T cell receptor transgenic mouse would be useful in research concerning the imm...
Adoptive cell immunotherapy for human diseases, including the use of T cells modified to express an ...
Engineering the immune system against cancer ideally provides surgical precision against the antigen...
Successful ex-vivo priming and long-term maintenance of anti-tumor cytotoxic T-cell (CTL) lines are ...
Transplantation experiments have demonstrated that most mouse tumors express antigens that can const...